Jeffrey R Jay insider trades: Adamas Pharmaceuticals (ADMS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC






and 5 more companies
Open-market buys and sales
49 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 21, 2017 | ADMS | ↓ Sell | 380,000 | $17.08 | $6.5M | Investment Mgr. | Jun 21, 2017 (0d) |
| Dec 17, 2014 | CNXR | ↓ Sell | 395,886 | $8.00 | $3.2M | By GPP-Connecture LLC | Dec 17, 2014 (0d) |
| Feb 10, 2011 | INFU | ↓ Sell | 2,070,000 | $2.26 | $4.7M | By Biomedical Offshore Value Fund, Ltd. | Feb 10, 2011 (0d) |
| Feb 10, 2011 | INFU | ↓ Sell | 1,984,542 | $2.26 | $4.5M | By Biomedical Value Fund, L.P. | Feb 10, 2011 (0d) |
| Feb 10, 2011 | INFU | ↓ Sell | 445,458 | $2.26 | $1.0M | By Biomedical Institutional Value Fund, | Feb 10, 2011 (0d) |
| Dec 8, 2008 | MEMY | ↓ Sell | 22,797 | $0.59 | $13K | By Biomedical Value Fund, L.P. | Dec 11, 2008 (3d) |
| Dec 8, 2008 | MEMY | ↓ Sell | 19,418 | $0.59 | $11K | By Biomedical Offshore Value Fund, Ltd. | Dec 11, 2008 (3d) |
| Dec 5, 2008 | MEMY | ↓ Sell | 527,702 | $0.59 | $311K | By Biomedical Value Fund, L.P. | Dec 11, 2008 (6d) |
| Dec 5, 2008 | MEMY | ↓ Sell | 449,523 | $0.59 | $265K | By Biomedical Offshore Value Fund, Ltd. | Dec 11, 2008 (6d) |
| Jul 8, 2008 | MEDE | ↓ Sell | 241,464 | $6.63 | $1.6M | By Biomedical Offshore Value Fund, Ltd. | Jul 9, 2008 (1d) |
| Jul 8, 2008 | MEDE | ↓ Sell | 135,723 | $6.58 | $893K | By Biomedical Value Fund, L.P. | Jul 9, 2008 (1d) |
| Jul 1, 2008 | MEDE | ↑ Buy | 161,755 | $6.65 | $1.1M | By Biomedical Value Fund, L.P. | Jul 9, 2008 (8d) |
| Nov 5, 2007 | MEMY | ↓ Sell | 205,092 | $1.02 | $210K | By Biomedical Value Fund, L.P. | Nov 6, 2007 (1d) |
| Nov 5, 2007 | MEMY | ↓ Sell | 174,708 | $1.02 | $179K | By Biomedical Offshore Value Fund, Ltd. | Nov 6, 2007 (1d) |
| Oct 23, 2007 | MEMY | ↓ Sell | 332,640 | $0.94 | $311K | By Biomedical Value Fund, L.P. | Oct 24, 2007 (1d) |
| Oct 22, 2007 | MEMY | ↓ Sell | 283,360 | $0.94 | $265K | By Biomedical Offshore Value Fund, Ltd. | Oct 24, 2007 (2d) |
| Oct 17, 2007 | MEMY | ↓ Sell | 463,860 | $0.95 | $439K | By Biomedical Value Fund, L.P. | Oct 22, 2007 (5d) |
| Oct 17, 2007 | MEMY | ↓ Sell | 395,140 | $0.95 | $374K | By Biomedical Offshore Value Fund, Ltd. | Oct 22, 2007 (5d) |
| Oct 16, 2007 | MEMY | ↓ Sell | 1,115,967 | $1.07 | $1.2M | By Biomedical Value Fund, L.P. | Oct 17, 2007 (1d) |
| Oct 16, 2007 | MEMY | ↓ Sell | 950,578 | $1.01 | $958K | By Biomedical Offshore Value Fund, Ltd. | Oct 17, 2007 (1d) |
| Jan 16, 2007 | ISPH | ↓ Sell | 270,000 | $7.31 | $2.0M | By Biomedical Value Fund, L.P. | Jan 18, 2007 (2d) |
| Jan 16, 2007 | ISPH | ↓ Sell | 230,000 | $7.31 | $1.7M | By Biomedical Offshore Value Fund, Ltd. | Jan 18, 2007 (2d) |
| Jun 28, 2006 | ISPH | ↑ Buy | 169,000 | $4.03 | $681K | By Biomedical Offshore Value Fund, Ltd. | Jun 30, 2006 (2d) |
| Jun 28, 2006 | ISPH | ↑ Buy | 156,000 | $4.03 | $629K | By Biomedical Value Fund, L.P. | Jun 30, 2006 (2d) |
| Mar 22, 2006 | AVM | ↓ Sell | 214,240 | $30.70 | $6.6M | By Biomedical Offshore Value Fund, Ltd. | Mar 23, 2006 (1d) |
| Mar 22, 2006 | AVM | ↓ Sell | 197,760 | $30.70 | $6.1M | By Biomedical Value Fund, L.P. | Mar 23, 2006 (1d) |
| Mar 20, 2006 | AVM | ↓ Sell | 53,560 | $31.58 | $1.7M | By Biomedical Offshore Value Fund, Ltd | Mar 21, 2006 (1d) |
| Mar 20, 2006 | AVM | ↓ Sell | 53,040 | $31.56 | $1.7M | By Biomedical Value Fund, L.P. | Mar 21, 2006 (1d) |
| Mar 17, 2006 | AVM | ↓ Sell | 3,900 | $31.25 | $122K | By Biomedical Offshore Value Fund, Ltd. | Mar 21, 2006 (4d) |
| Mar 16, 2006 | AMV | ↓ Sell | 31,772 | $30.39 | $965K | By Biomedical Offshore Value Fund, L.P. | Mar 17, 2006 (1d) |
| Mar 16, 2006 | AMV | ↓ Sell | 30,720 | $29.84 | $917K | By Biomedical Value Fund, L.P. | Mar 17, 2006 (1d) |
| Mar 16, 2006 | AMV | ↓ Sell | 15,600 | $29.49 | $460K | By Biomedical Offshore Value Fund, L.P. | Mar 17, 2006 (1d) |
| Mar 16, 2006 | AMV | ↓ Sell | 13,008 | $30.67 | $399K | By Biomedical Value Fund, L.P. | Mar 17, 2006 (1d) |
| Mar 2, 2006 | AVM | ↓ Sell | 21,944 | $25.43 | $558K | By Biomedical Offshore Value Fund, Ltd. | Mar 6, 2006 (4d) |
| Mar 2, 2006 | AVM | ↓ Sell | 20,256 | $25.43 | $515K | By Biomedical Value Fund, L.P. | Mar 6, 2006 (4d) |
| Feb 28, 2006 | AVM | ↓ Sell | 35,026 | $25.25 | $885K | By Biomedical Value Fund, L.P. | Mar 2, 2006 (2d) |
| Feb 28, 2006 | AVM | ↓ Sell | 5,820 | $25.20 | $147K | By Biomedical Offshore Value Fund, Ltd. | Mar 2, 2006 (2d) |
| Feb 27, 2006 | AVM | ↓ Sell | 2,454 | $25.25 | $62K | By Biomedical Offshore Value Fund, Ltd. | Mar 2, 2006 (3d) |
| Feb 21, 2006 | AVM | ↓ Sell | 29,500 | $25.42 | $750K | By Biomedical Value Fund, L.P. | Feb 23, 2006 (2d) |
| Aug 25, 2005 | PANC | ↓ Sell | 66,693 | $10.28 | $685K | By Biomedical Value Fund, L.P. | Aug 29, 2005 (4d) |
| Aug 25, 2005 | PANC | ↓ Sell | 66,692 | $10.28 | $685K | By Biomedical Offshore Value Fund, Ltd. | Aug 29, 2005 (4d) |
| Aug 24, 2005 | PANC | ↓ Sell | 105,500 | $9.60 | $1.0M | By Biomedical Offshore Value Fund, Ltd. | Aug 25, 2005 (1d) |
| Aug 24, 2005 | PANC | ↓ Sell | 105,500 | $9.60 | $1.0M | By Biomedical Value Fund, L.P. | Aug 25, 2005 (1d) |
| Aug 23, 2005 | PANC | ↓ Sell | 1,460,500 | $10.85 | $15.8M | By Biomedical Value Fund, L.P. | Aug 24, 2005 (1d) |
| Aug 23, 2005 | PANC | ↓ Sell | 610,500 | $10.84 | $6.6M | By Biomedical Offshore Value Fund, Ltd. | Aug 24, 2005 (1d) |
| Jul 19, 2005 | VITX | ↓ Sell | 250,000 | $6.65 | $1.7M | By Biomedical Offshore Value Fund, Ltd. | Jul 21, 2005 (2d) |
| Jul 19, 2005 | VITX | ↓ Sell | 250,000 | $6.65 | $1.7M | By Biomedical Value Fund, L.P. | Jul 21, 2005 (2d) |
| Jul 12, 2005 | VITX | ↓ Sell | 750,000 | $5.30 | $4.0M | By Biomedical Value Fund, L.P. | Jul 12, 2005 (0d) |
| Jul 12, 2005 | VITX | ↓ Sell | 750,000 | $5.30 | $4.0M | By Biomedical Offshore Value Fund, Ltd. | Jul 12, 2005 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Jeffrey R Jay's insider trades
Jeffrey R Jay is a 10% owner of Adamas Pharmaceuticals (ADMS). Since Jul 12, 2005, Jeffrey has reported 3 open-market purchases worth $2.4M and 46 sales worth $89.4M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (2 filings), option exercises (2 filings), gifts (1 filing), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ADMS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.